摘要
目的观察当肝癌细胞的DNA损伤时三结构域蛋白28(Trim28)磷酸化对其生存能力的影响.方法将Hepg2细胞系分为SB203580+UV组及UV组.用紫外线(UV)照射Hepg2细胞建立Hepg2细胞DNA损伤的模型,SB203580+UV组在UV照射后使用Trim28磷酸化抑制剂SB203580处理细胞.通过蛋白质印迹法(Western blot)检测上述处理后两组细胞的Trim28、磷酸化Trim28 ser473(p-Trim28 ser473)的表达;通过噻唑蓝(MTT)实验观察上述处理后Hepg2细胞的生存能力.结果SB203580+UV(0.96±0.16)组与UV组(0.94±0.13)的Trim28表达比较,差异无统计学意义(t=-0.190,P>0.05);,SB203580+UV组p-Trim28(0.32±0.04)明显低于UV组(0.72±0.05),差异有统计学意义(t=8.500,P<0.05);紫外线照射后24、48、72 h UV组细胞生存率[(95±7)%、(62±10)%、(35±6)%]明显高于SB203580+UV组[(85±7)%、(37±4)%、(20±3)%],差异有统计学意义(t=-2.326、-5.212、-4.577,P<0.05).结论当肝癌细胞DNA损伤时抑制Trim28(ser473)磷酸化可以降低癌细胞的生存能力.
Objective To observe effect of Trim28(ser473)phosphorylation on viability of hepatocellular carcinoma(HCC)cells during DNA damage.Methods To divide Hepg2 cells into 2 groups as SB203580+UV group and UV group.Hepg2 cells were modeled for DNA damage by UV(Ultraviolet)irradiation.SB2035804-UV group was treated with Trim28 phosphorylation inhibitor SB203580 after UV irradiation.Expression of Trim28 and phosphorylation-Trim28 ser473(P-Trim28 ser473)were detected by westemblot experiment.The viability of Hepg2 cells were observed by methyl thiazol tetrazolium(MTT)experiment.Results Compared with UV group(0.94±0.13),the expression value of Trim28 in SB203580+UV group had no significant difference(t=-0.190,P>0.05).Value of phosphorylation-Trim28 in SB203580+UV group(0.32±0.04)was obviously lower than UV group(0.72±0.05),the difference had statistical meaning(t=8.500),P<0.05);The 24,48 and 72 hours after UV irradiation,the cell survive rate of UV group[(95±7)%,(62±10)%,(35±6)%]is higher than SB203580+UV group[(85±7)%,(37±4)%,(20±3)%].The difference has statistical meaning(t=-2.326,-5.212,-4.577,P<0.05).Conclusion The viability of HCC cells during DNA damaged can be reduced by inhibition for Trim28 phosphorylation.
作者
王永亮
翟淑萍
王百林
苑伟
王鹏珍
张旭
贾伟路
袁辉
Wang Yongliang;Zhai Shupin;Wang Bailin;Yuan Wei;Wang Pengzhen;Zhang Xu;Jia Weilu;Yuan Hui(The First Medical College of Guizhou Medical University,College of Clinical Medicine,Guiyang 550004,China;Department of General Surgery,Guangzhou Red Cross Hospital,Medical College,Jinan University,Guangzhou 510220,China;Traumatic Surgery Research Institute,Guangzhou 510220,China)
出处
《中华实验外科杂志》
CAS
CSCD
北大核心
2019年第12期2187-2189,共3页
Chinese Journal of Experimental Surgery
基金
2017年广东省医学科学技术研究基金(A2017445)
2017年广州市医药卫生科技项目(20171A010258)。